Universe Pharmaceuticals INC Increase (Decrease) in Accounts Receivable
Universe Pharmaceuticals INC (UPC) reported Increase (Decrease) in Accounts Receivable of $168.96 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-01-29
| Period end | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $168.96M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $1.55B 20-F · filed 2026-01-29 | $1.55M 20-F · filed 2025-04-29 | |
| 2024-03-31 | $3.35M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | -$4.72B 20-F · filed 2026-01-29 | -$4.72M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $1.76M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $1.53M 20-F · filed 2025-04-29 | $1.55M 20-F · filed 2023-02-10 | |
| 2022-03-31 | $3.06M 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $3.87M 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $6.32M 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $4.11M 20-F · filed 2023-02-10 | ||
| 2019-09-30 | -$665.49K 20-F · filed 2022-01-31 |